CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Latest News

The FIRCE-1 trial of firi-cel in relapsed/refractory large B-cell lymphoma has been discontinued. | nobeastsofierce - stock.adobe.com.
Phase 2 Trial of Firi-Cel CAR T-Cell Therapy Discontinued in Lymphoma

February 12th 2025

The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been discontinued.

FDA approves Adcetris plus Revlimid and Rituxan relapsed or refractory large B-cell lymphoma.
FDA Approves Adcetris With Revlimid and Rituxan For R/R LBCL

February 12th 2025

Dr. Tycel Phillips discusses the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL. | © Digilife - stock.adobe.com
FDA Approval of Calquence Combo Brings Optimism in MCL

February 11th 2025

Illustration of blood cells.
Opdivo Plus Chemo May Be Effective and Safe in Older Patients with cHL

February 6th 2025

An image of a doctor taking notes.
Whitesnake Guitarist John Sykes Died of Cancer, Mike Peters Starting CAR-T

January 24th 2025

More News